user
menu
letter
Sign InRegister
langEnglisharrow

HLA-A*2402 & B2M & EBV BRLF1 (TYPVLEEMF)

HLA-A*2402 & B2M & EBV BRLF1 (TYPVLEEMF) 製品リスト

  • 属性

    Protein (1)

  • 製品ライブラリ

    オンライン (1)

  • 種

    Human (1)

  • タグ

    His Tag & Avi Tag (1)

  • マーカー

    Unconjugated (1)

製品番号種発現システム製品説明タンパク質の構造純度特性
HLF-H52E5
Human
HEK293
Unconjugated Human HLA-A*24:02&B2M&EBV BRLF1 (TYPVLEEMF) Complex Protein (Monomer, MALS verified)
総数量1
  • 1
お問い合わせ

HLA-A*2402 & B2M & EBV BRLF1 (TYPVLEEMF)バックグランド

This is a recombinant protein complex of HLA-A*24:02 presenting an immunodominant 9-mer peptide (TYPVLEEMF) derived from the Epstein-Barr virus (EBV) immediate-early transactivator BRLF1. HLA-A*24:02 is a common class I allele, and this peptide is a well-characterized target for CD8⁺ T cells in EBV-seropositive individuals, making the complex a valuable tool for studying antigen-specific T cell responses in viral immunity and immunotherapies.

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
CHM-2101CDH17-CAR T; CHM-2101; CHM2101; CHM-2101 CAR-T cellsPhase 2 ClinicalUniversity Of PennsylvaniaStomach Neoplasms; Pancreatic Neoplasms; Neuroendocrine Tumors; Colorectal Neoplasms; Gastrointestinal Neoplasms
詳細
BI-905711BI-905711Phase 1 ClinicalBoehringer Ingelheim GmbhPancreatic Neoplasms; Cholangiocarcinoma; Gastrointestinal Neoplasms
詳細
ARB-202ARB-202Phase 1 ClinicalArbele CorpLiver Neoplasms; Biliary Tract Neoplasms; Stomach Neoplasms; Pancreatic Neoplasms; Cholangiocarcinoma; Colorectal Neoplasms; Esophageal adenocarcinoma; Gastrointestinal Neoplasms
詳細
  • 製品リスト
  • 治験薬に関する情報